Inhaled Mycotoxins and Testing: What Patients Need to Know

Many patients ask about mould, mycotoxins, and private test panels — especially when symptoms overlap with conditions like aspergillosis, asthma, or MCAS (see glossary). The science is complex, and there’s a lot of misinformation online. Here’s what we know.

Can inhaled mycotoxins cause illness?

  • High exposure at work: In farming, animal feed, waste handling, or recycling, workers can breathe in dusts that contain fungal fragments and mycotoxins. At these levels, people may develop work-related asthma, cough, or “organic dust toxic syndrome.”

  • Homes and offices: Damp and mouldy buildings are consistently linked to worse asthma and respiratory symptoms. But experts (WHO, Institute of Medicine, CDC, MHRA) stress that it’s not just mycotoxins — spores, allergens, β-glucans, and bacteria all play a role.

  • Bottom line: Dampness and mould are unhealthy, but there’s limited proof that airborne mycotoxins alone at household levels cause chronic illness. The key intervention is always fixing damp and mould, improving ventilation, and managing lung conditions properly.

Why are private mycotoxin tests offered?

Despite the limited evidence, urine and blood “mycotoxin panels” are marketed by private labs (often in the US). They detect tiny traces of toxins that almost everyone has — mostly from food.

Why they exist:

  • People with real symptoms want answers, and commercial labs meet that demand.

  • It is technically possible to measure mycotoxins, even if the meaning is unclear.

  • Some alternative practitioners use them because patients want something tangible.

Why are these tests unreliable?

  1. Everyone has some exposure – Sensitive tests will almost always find traces from normal diet, even in healthy people.

  2. No agreed cut-offs – No international standards for what level in blood/urine is “safe” or “unsafe.”

  3. Not validated for diagnosis – NHS, WHO, CDC, EMA do not accept these tests as diagnostic.

  4. Can’t show source – They can’t distinguish whether the toxin came from food, dust, or infection.

  5. Risk of unnecessary treatment – May push people toward costly, unproven therapies.

👉 Bottom line: A positive result usually reflects diet, not disease. That’s why NHS doctors don’t use these tests.

Why validation matters

For any medical test to be trusted, it must go through validation:

  1. Analytical validation – does the test reliably measure what it claims?

  2. Clinical validation – does it correctly identify people with the disease and exclude those without it?

  3. Clinical utility – does it actually help doctors make better treatment decisions?

  4. Regulatory approval – bodies like the MHRA (UK), FDA (US), and EMA (EU) ensure tests are safe and meaningful before routine use.

Without validation, a test can give results that look scientific but don’t guide care. That’s why the NHS doesn’t accept mycotoxin blood or urine testing — they haven’t been shown to make diagnoses more accurate or treatments more effective.

What if your mycotoxin test is positive, but you don’t live in a damp home?

This is very common.

  • Food is the main source: Mycotoxins are often found in grains, nuts, coffee, and dried fruit.

  • Exposure ≠ illness: A positive only shows contact, not harm.

  • No NHS role: Since the tests can’t separate harmless from harmful exposure, they aren’t used.

  • What matters most: If you’re unwell, validated NHS tests (CT scans, Aspergillus IgE/IgG, sputum cultures) guide proper diagnosis and treatment.

Foods that can contain mycotoxins

  • Aflatoxins – peanuts, maize, tree nuts, dried fruit, spices.

  • Ochratoxin A – coffee, dried fruit, wine, cereals.

  • Fumonisins, zearalenone, DON – maize, wheat, cereals.

  • Patulin – apples and apple juice.

  • Gliotoxin – made by Aspergillus fumigatus; occasionally found in mouldy cereals/silage, but mainly important when produced inside the body during invasive aspergillosis.

👉 In the UK/EU, foods are routinely monitored and regulated to keep levels very low.

What this means for patients

  • If you have aspergillosis or asthma, mould can worsen symptoms — but NHS doctors use validated tests, not private toxin panels.

  • If you feel unwell in a mouldy home, focus on fixing damp and talking to your GP or specialist.

  • A positive mycotoxin test without damp exposure almost always reflects normal diet.

  • Be cautious about spending money on unvalidated tests, which don’t change safe NHS treatment.

💙 Key message: Damp and mould can harm health, and sometimes mycotoxins are part of that story. But unvalidated mycotoxin blood/urine tests are unreliable and not used by the NHS. The safest approach is to fix damp, protect your lungs, and rely on NHS-approved diagnostics and treatments.

Glossary of Terms

  • WHO – World Health Organization, the UN’s global health authority.

  • CDC – Centers for Disease Control and Prevention, the main US public health body.

  • EMA – European Medicines Agency, which regulates medicines across the European Union.

  • MHRA – Medicines and Healthcare products Regulatory Agency, the UK body that regulates medicines and devices.

  • NHS – National Health Service, the publicly funded health system in the UK.

  • IgE / IgG – Immunoglobulin E and Immunoglobulin G, types of antibodies measured in blood tests to check for allergy or immune response.

  • CT scan – Computed Tomography scan, a detailed type of X-ray that shows cross-sections of the body.

  • MCAS – Mast Cell Activation Syndrome, a condition where mast cells release too many chemicals, causing allergic-type symptoms.

  • ABPA – Allergic Bronchopulmonary Aspergillosis, an allergic lung condition caused by reaction to Aspergillus.

  • CPA – Chronic Pulmonary Aspergillosis, a long-term fungal infection of the lungs caused by Aspergillus.

by GAtherton

Voriconazole and Sun Sensitivity: What Patients Can Do

Voriconazole is an important antifungal, but it can make your skin much more sensitive to sunlight. Some people develop mild rashes, while others can get severe sunburn even after only a few minutes outdoors.

🌞 Protect your skin every day

  • High-factor sunscreen (SPF 50+) on all exposed skin, even in winter or cloudy weather.

  • Lip balm with SPF for lips, which are often affected.

  • Protective clothing: hats, long sleeves, UV-blocking fabrics if possible.

  • Avoid peak sun (11am–3pm) and try to stay in shade when outdoors.

👀 Watch your skin closely

  • Report any new rashes, blisters, lumps, or patches to your specialist team.

  • Regular skin checks may be offered if you are on long-term voriconazole.

💊 Medication review

  • If severe reactions develop, your doctors may:

    • Adjust the dose

    • Switch you to another antifungal (e.g. posaconazole, isavuconazole)

    • Add specialist dermatology follow-up

🚨 When to act fast

Seek medical advice urgently if you develop:

  • Blistering burns after short sun exposure

  • Painful or rapidly changing skin lesions

  • Any signs of infection in damaged skin

💙 Key message for patients: Sun sensitivity on voriconazole is common enough that everyone should take precautions. Don’t wait until your skin is badly affected — protect daily, and tell your team about any changes.

by GAtherton

Drug Safety in the UK: What Aspergillosis Patients Need to Know

Living with aspergillosis often means taking powerful medicines for a long time — antifungals, steroids, antibiotics, or even biologics. These treatments can be life-saving, but they can also cause side effects, especially when used together. It’s natural to wonder: How do we know these drugs are safe? What happens if something goes wrong?

This article explains how drug safety is managed in the UK, what happens when rare problems occur, and what resources patients can use to protect themselves.

How Medicine Safety Works

Before a drug is approved:
Every new medicine goes through several phases of clinical trials. These trials are not just about proving that the drug works (efficacy) — they are also about proving it is safe enough to use in people. Researchers record every possible side effect, monitor blood tests, and look for safety signals as well as improvements in the illness.

However, trials have limits. They usually include only a few thousand participants, so they can reliably detect common side effects but not very rare ones. For example, if a side effect happens in 1 in 100,000 people, and a trial only studies 50,000, it may not appear at all.

After a drug is approved:
Once a medicine is prescribed to thousands or millions of people, those rare side effects start to appear. For example, in the first million patients, perhaps 10 cases may be reported. That’s not manipulation — it’s just the maths of large numbers.

How Do Doctors Link a Side Effect to a Medicine?

When someone develops a new symptom, it isn’t always obvious whether it’s caused by their illness, another condition, or the medicine they’re taking. Linking a side effect to a drug usually involves several steps:

  1. Timing – Did the symptom start soon after beginning the medicine? Did it improve when the medicine was stopped? Timing is often the strongest clue.

  2. Known side effect profile – Doctors check if the symptom has been reported before in trials, studies, or drug safety updates.

  3. Other explanations – Could it be the underlying condition (like aspergillosis) or another drug? All possible causes are reviewed.

  4. Drug interactions – Many side effects come from the way medicines interact, rather than one drug alone. Antifungals like itraconazole and voriconazole interact with steroids, antibiotics, and heart drugs.

  5. Rechallenge (rarely used) – Sometimes a drug is restarted to see if the side effect returns. This can provide strong evidence but is only done when absolutely necessary.

  6. Patient reporting – A single case may not prove much, but when dozens of patients report the same issue, patterns become clear.

🔎 Key message: It’s not always quick or simple to prove a side effect. That’s why your own observations — when it started, how it feels, what other medicines you’re on — are so valuable to your doctors and to the Yellow Card system.

What Happens to Those Patients?

  • Every case is recorded and investigated. Regulators like the MHRA (Medicines and Healthcare products Regulatory Agency) look for patterns.

  • If a link is confirmed, they can issue warnings, add monitoring requirements, restrict use, or withdraw the drug.

  • For the patients affected, the drug is usually stopped, and supportive treatment is given. Sadly, in some cases, harm cannot be reversed.

This is why reporting side effects is so important. Each individual case helps build the full safety picture and protects others in the future.

Is This “Experimenting on Patients”?

It can sometimes feel that way — because new medicines are still watched closely after approval, and some harms are only seen later.

But there’s an important distinction:

  • Clinical trials are the experiments, and they are about safety as much as efficacy. Every trial phase collects safety data, and a medicine cannot be approved unless it is shown to be safe enough for use.

  • Post-marketing monitoring is not an experiment — it’s a safety net that exists for all medicines, because no trial is ever large enough to catch every very rare problem.

Patients aren’t being experimented on after approval, but your experience does matter. Every report adds to knowledge and helps keep medicines safe for everyone.

Who Is Liable If Harm Occurs?

  • Negligence (e.g. wrong dose, ignoring abnormal tests): the prescriber or hospital may be liable.

  • Defective product or hidden data: the manufacturer may be held responsible, sometimes through compensation schemes or legal action.

  • Very rare, unpredictable events despite correct use: liability is often less clear, and compensation is not guaranteed.

This can feel unfair. A few patients may suffer harm without anyone being “at fault.” That’s why strong safety monitoring and reporting are so essential.

Balancing Benefit and Risk

If 10 people out of a million are harmed, 999,990 people may have been helped — often in life-saving ways. That doesn’t make the harm any less real, but it explains why regulators still approve medicines with very rare risks: the benefit to the vast majority outweighs the small chance of harm, as long as those harms are recognised and acted on quickly.

Looking forward, science may allow us to predict who is at risk of those 1-in-a-million harms (through genetics or biomarkers) and screen them out — so that only those who can benefit safely receive the drug.

Key UK Drug Safety Resources

Here are the most useful resources for patients in the UK:

What Aspergillosis Patients Need to Remember

Because aspergillosis often requires long-term, powerful medicines like itraconazole, voriconazole, posaconazole, steroids, or biologics, patients are more likely to:

  • Experience side effects

  • Need regular blood tests to check drug levels

  • Take multiple medicines with possible interactions

Three key takeaways:

  1. Know where to look – check NHS Medicines A–Z or your medicine leaflet (eMC) if you’re unsure about a side effect.

  2. Report problems – use the Yellow Card scheme to flag any suspected reaction.

  3. Stay in touch with your team – never stop or change your medicine without advice, but do share new symptoms with your GP or specialist promptly.

✅ Bottom line: Clinical trials test both safety and effectiveness, but no study can capture every rare event. That’s why medicines continue to be monitored after approval, and why patient reporting is so important. By working together — patients, doctors, and regulators — we make medicines safer for everyone.

by GAtherton

🩺 Monitoring your health at home with aspergillosis

Many people with aspergillosis (ABPA, CPA, SAFS, aspergillus bronchitis) now use home devices such as pulse oximeters, blood pressure monitors, and thermometers. These are very useful tools — but only if you know how to take reliable measurements and when to act on them.

⚠️ Important: These devices are only guides. If you feel unwell, worsening, or unsafe — seek help, even if the numbers look “normal.” How you feel is always more important than a single reading.

This guide explains:

  1. ✅ How to measure correctly

  2. 🟢 When to relax, 🟠 when to monitor, 🔴 when to seek help

  3. ⚠️ What’s different if you have other health conditions

📏 How to take reliable measurements

🌡 Temperature

  • Use a digital thermometer (ear, mouth, or underarm).

  • Take your temperature at the same time each day when well, to learn your baseline.

  • Avoid measuring straight after a hot drink, bath, or exercise.

  • Always use the same device and method for consistency.

  • ⚠️ Normal isn’t the same for everyone:

    • Typical range is 36.1–37.2 °C.

    • Some people naturally run a little “cooler” or “warmer.”

    • Temperature changes with time of day, age, hormones, and medicines (e.g. steroids, paracetamol).

    • Your personal baseline is most important.

💨 Oxygen saturation (SpO₂)

  • Sit quietly and rest for 5 minutes before checking.

  • Warm your hands — cold fingers reduce accuracy.

  • Remove nail polish, gel nails, or false nails.

  • Place the oximeter on your index or middle finger.

  • Keep your hand still, relaxed, and at heart level.

  • Wait 30–60 seconds until numbers settle, then record both SpO₂ and pulse.

❤️ Pulse rate

  • Normally shown on your oximeter.

  • Measure when sitting calmly.

  • If irregular, double-check manually by counting your pulse at the wrist or neck for 30 seconds ×2.

  • Record alongside oxygen reading.

🔹 Blood pressure (BP)

  • Rest for 5 minutes before measuring.

  • Use the same arm each time (usually left).

  • Keep your arm supported at heart level.

  • Sit with feet flat on the floor, legs uncrossed.

  • Avoid caffeine, smoking, or exercise for 30 minutes before.

  • Take two readings, 1–2 minutes apart, and record the average.

📝 Recording results

  • Note date, time, reading, and how you feel.

  • Keep a diary or use an app to spot trends over time.

  • Share with your GP or specialist, especially if you reach “amber” or “red” zones.

📊 When to seek help — traffic light system

⚠️ Don’t rely on numbers alone. If you feel unwell, dizzy, very breathless, confused, or unsafe, seek medical help — even if your readings are in the “green” zone.

🌡 Temperature

  • Green (OK): Within your baseline range.

  • Amber (monitor/GP): ≥37.5 °C repeatedly, or ≥1 °C above your baseline.

  • Red (urgent help): ≥38 °C once with feeling unwell; any fever with severe breathlessness, chest pain, or confusion.

💨 Oxygen saturation (SpO₂)

  • Green (OK): 93–100% (or your personal baseline).

  • Amber (monitor/GP): Drop of ≥3% from normal; persistent 89–92% at rest; dips after mild exertion that recover slowly.

  • Red (urgent help): ≤88% at rest, or sudden fall with confusion, blue lips/fingers, severe breathlessness.

❤️ Pulse rate

  • Green (OK): 60–100 bpm at rest, regular.

  • Amber (monitor/GP): >100 but <120 bpm; <50 bpm with fatigue/dizziness; irregular pulse.

  • Red (urgent help): >120 bpm at rest; chest pain, collapse, or fainting.

🔹 Blood pressure (BP)

  • Green (OK): 100/60 – 140/90 (unless advised otherwise).

  • Amber (monitor/GP): Systolic >150 or <95; diastolic >95 or <60 on repeated readings.

  • Red (urgent help): ≥180/110, or systolic <80 with dizziness, fainting, or collapse.

⚠️ Comorbidities: special considerations

If you have other health conditions, your safe ranges may be different:

  • COPD or severe chronic lung disease → Oxygen targets are usually 88–92% (not higher).

  • Heart disease or pulmonary hypertension → Leg swelling + falling oxygen may need urgent review.

  • Atrial fibrillation / irregular heart rhythm → Oximeters may give unreliable pulse readings. Confirm with your GP or specialist.

  • Diabetes or thyroid problems → Can affect pulse rate and blood pressure; your “green” zone may differ.

  • Kidney disease, diabetes, cardiovascular disease → Stricter BP targets may apply (often <130/80).

  • Older age or steroid/immune-suppressing treatment → You may not get a high fever with infection. Even a small rise above your baseline could be important.

👉 Always ask your clinician:

  • “What’s my personal safe oxygen range?”

  • “What blood pressure or pulse numbers should trigger a call for me?”

⚠️ Other warning signs to act on

  • Sudden increase in sputum (more volume, colour change, or blood-streaked)

  • Fever with worsening cough or breathlessness

  • Rapid swelling of legs, ankles, or abdomen

  • New confusion, drowsiness, or severe fatigue

🟢 AMBER RED system

  • Green: Stay calm, record readings.

  • Amber: If new or persisting >24–48 hours, contact your GP or specialist.

  • Red: Seek urgent medical help (999 / A&E).

✅ Key message:
Home monitors are helpful, but they don’t replace how you feel. Always act on symptoms first — numbers are just part of the picture. If in doubt, seek medical advice.

by GAtherton

Medicine Leaflets, Side Effects, and Interactions: Where to Find Reliable Information

When you open a new box of medicine, you’ll usually find a folded sheet of paper inside — the Patient Information Leaflet (PIL). These leaflets are important, but they can be hard to read because of the tiny print and the amount of information squeezed onto the page.

Patients often ask: Where does this information come from? What if I can’t read it? And how do I check for drug interactions as well as side effects?

Here’s what you need to know.

1. Where do leaflets come from?

  • Written by the manufacturer – The drug company that makes the medicine is legally required to prepare the leaflet.

  • Checked by regulators – In the UK, the MHRA (Medicines and Healthcare products Regulatory Agency) reviews and approves the leaflet before the medicine is sold. In Europe, this role is carried out by the EMA.

  • Updated regularly – If new safety information comes to light (for example, through the Yellow Card reporting system), the leaflet must be revised and re-approved.

By law, leaflets must include:

  • What the medicine is for.

  • Who can and cannot take it.

  • How to take it.

  • Side effects and how common they are.

  • Possible drug interactions.

  • Storage instructions.

  • How to report suspected side effects.

2. Why the text is so small

Because there’s so much information to fit into a tiny folded sheet, the print is often very small and difficult to read. For many patients, the leaflet in the box just isn’t practical.

3. Where to find more readable versions

If the leaflet is hard to read, you have better options:

  • Electronic Medicines Compendium (eMC)

    • www.medicines.org.uk/emc

    • Up-to-date PILs and professional information for nearly all UK-licensed medicines.

    • Easy to zoom, search, and print in large text.

  • BNF (British National Formulary)

    • bnf.nice.org.uk

    • Trusted source for doctors and pharmacists, but also useful for patients.

    • Lists side effects, cautions, and drug interactions clearly.

  • NHS.uk

  • Pharmacist

    • Can print a large-text version of the leaflet.

    • Can check for interactions with other medicines you take.

    • Some companies provide Braille, audio, or large-print versions on request.

4. Where to check drug interactions

Drug interactions are just as important as side effects, because they can make medicines stronger, weaker, or more dangerous.

  • BNF online (bnf.nice.org.uk) – the best source in the UK, used by clinicians, with a clear section on interactions.

  • eMC (SmPC section) – each drug’s Summary of Product Characteristics includes detailed interaction data.

  • Pharmacist or GP – the safest and most personal check, since they know your full medication list.

  • Hospital specialists – especially important if you are on antifungals, as these interact with many other medicines.

5. The bottom line

Medicine leaflets are carefully written, regulated documents — but the folded sheet in your box isn’t the only option, and it’s often not the easiest to use.

👉 You don’t have to struggle with tiny print. Reliable, readable versions are available online (eMC, BNF, NHS.uk), and your pharmacist can explain and print large-text copies.

👉 For drug interactions, never rely on random internet sources — use the BNF, eMC, or your healthcare team.

And if you’re ever unsure, ask your doctor or pharmacist before starting anything new, including over-the-counter medicines or supplements.

by GAtherton

Side Effects, New Medicines, and Safety Reporting: What Every Patient Should Know

Modern medicines, including antifungals used for aspergillosis, can be life-saving. But they can also have powerful side effects. One patient recently described developing nerve damage (neuropathy) while on treatment, but never mentioned it to their doctor, because they didn’t know it could be a side effect. Sadly, by the time it was recognised, the damage was permanent.

This story shows why patients and doctors need to work together in partnership to spot and report side effects early — especially when medicines are new and real-world safety data is still limited.

1. From passive role to partnership

In the past, healthcare was one-way: the doctor gave instructions, the patient followed. Today the NHS encourages shared responsibility:

  • Doctors bring their expertise about the illness and treatments.

  • Patients bring their daily experience of living with the condition.

  • Together they can make safer, better-informed decisions.

This partnership is essential for powerful drugs like antifungals, where side effect monitoring depends on both sides working together.

2. Why side effect statistics can be misleading

Leaflets list side effects as “common” or “rare,” often with percentages. But these figures don’t always reflect real life because:

  • Trials are limited – only a few thousand people take part, often younger and healthier than typical NHS patients.

  • Under-reporting is common – doctors and patients often fail to report side effects, especially mild ones.

  • Bias exists – severe or unusual reactions are reported more often than everyday ones.

👉 Bottom line: leaflets tell us what can happen, not always how often it happens.

3. The Yellow Card system

The UK’s main tool for detecting safety issues is the Yellow Card Scheme, run by the MHRA.

  • Anyone can report: doctors, nurses, pharmacists, patients, or carers.

  • Reports are vital: patterns in these reports may reveal risks not seen in trials.

  • Action is taken: if needed, leaflets are updated, warnings issued, or drugs restricted/withdrawn.

You can report suspected side effects at yellowcard.mhra.gov.uk.

4. Why reporting matters

Poor reporting leads to harm:

  • Delayed warnings – e.g. photosensitivity with voriconazole took years to be recognised.

  • Biased safety data – drugs may seem safer than they are.

  • Preventable harm – patients may suffer permanent injury before action is taken.

For new medicines (marked with a ▼ black triangle in the BNF and leaflets), the MHRA asks for all side effects to be reported, no matter how small.

5. Extra protections for new medicines

When a drug is new, safety systems are stronger than usual:

  • Black triangle (▼) – signals “additional monitoring” so all suspected ADRs should be reported.

  • Specialist prescribing – new antifungals are usually limited to centres like NAC.

  • Closer monitoring – frequent blood tests, drug levels, eye or skin checks depending on risk.

  • Risk Management Plans – agreed with regulators, spelling out what to watch for.

  • Post-marketing studies – Phase 4 trials track safety in real-world patients.

These safeguards are extensive, but not fool-proof. Rare or long-term effects may still emerge only after years of wider use.

6. The NHS challenge

Despite the systems:

  • Only a small percentage of doctors file Yellow Card reports each year.

  • Most GPs never prescribe brand-new drugs — so reporting falls heavily on specialist centres like NAC.

  • Under-reporting risks harm, increases NHS costs, and erodes trust.

7. Who sets the rules?

Several organisations provide guidance on reporting and safety:

  • MHRA (UK regulator): runs Yellow Card, monitors new and established drugs, and issues safety updates.

  • BNF (British National Formulary): highlights side effects, black triangle drugs, and links to reporting tools.

  • GMC (General Medical Council): obliges doctors to report serious ADRs and all reactions to ▼ drugs.

  • EMA (European Medicines Agency): operates EudraVigilance, pooling reports from across Europe.

  • Global standards: the UK follows international rules (ICH E2B) so data is shared worldwide.

8. What patients can do

You are central to this safety net:

  • Be observant – notice anything new or unusual.

  • Keep a record – note when it started, how often, and any changes with medication.

  • Report promptly – tell your team and consider submitting a Yellow Card yourself.

  • Ask questions – “What side effects should I look out for? Which are urgent? How will we monitor this drug?”

  • Use trusted sources – NHS.uk, bnf.nice.org.uk, NAC, or your pharmacist.

9. The reality of side effects

For many, side effects are not “minor inconveniences.” They can mean:

  • Permanent disability (e.g. nerve or vision damage).

  • Loss of independence or mobility.

  • Social isolation and depression.

That’s why side effect monitoring is not just bureaucracy — it’s about protecting real lives.

Key message

The systems around new medicines are extensive but not fool-proof. That’s why patients and doctors must work as partners.

👉 If you notice something new, strange, or worrying while on antifungal medication — however small — tell your healthcare team and consider reporting it. Your report may be the missing piece that protects you and others.

by GAtherton

Working With Your Medical Team: What Every Patient With Aspergillosis Needs to Know

Modern antifungal treatments, and many of the medicines used alongside them, can be life-saving. They help control infections that would otherwise cause severe damage to the lungs and other organs. But these medicines are also powerful, and like all strong treatments, they sometimes carry risks.

One patient recently shared that they developed nerve damage (neuropathy) while taking antifungal medication, but did not mention it to their doctor because they did not know it could be a side effect. Sadly, problems like this can sometimes become permanent if not spotted early.

This raises an important question: what do patients need to know about their responsibilities when taking medicines like antifungals, and more broadly, when living with aspergillosis?

From passive role to partnership

In the past, healthcare often worked in one direction: the doctor gave instructions, and the patient was expected to follow them. Patients were mostly passive, with little chance to ask questions or take part in decisions.

The NHS is now moving towards a very different way of working: partnership.

This means:

  • Doctors and nurses share their medical knowledge.

  • Patients share their experiences of living with their condition.

  • Together, both sides decide what treatment and care will work best.

Why doctors sometimes hesitate about side effects

Some patients are surprised to learn that not all doctors automatically tell patients about possible side effects. Why is this?

  • Some worry about causing anxiety or putting patients off treatment.

  • Others fear the nocebo effect — where simply knowing about a side effect can make someone more likely to notice it.

  • They may also feel that handing over a long list of possible effects is overwhelming.

But when it comes to antifungals and other long-term, powerful medicines, not knowing can be dangerous. If patients do not know what to look for, they may ignore early signs of serious problems until it is too late.

The best approach is balance:

  • Patients don’t need to memorise an endless list.

  • They do need a clear, short list of the most important and urgent symptoms to look out for — and to know what to do if they appear.

Medicines: what patients should do

  • Take medicines as prescribed – antifungals, inhalers, steroids, or biologics must be taken on schedule. Missing doses can reduce effectiveness or drive resistance.

  • Do not stop suddenly – especially steroids. Always follow tapering advice.

  • Check for interactions – antifungals can clash with common medicines such as statins, blood pressure tablets, and painkillers. Always tell your team about new prescriptions, over-the-counter drugs, or supplements.

  • Use the same pharmacy if possible – so interactions are checked consistently.

Monitoring your health

  • Attend all scheduled tests – blood work, lung function, CT scans. These can reveal hidden changes before you feel them.

  • Know your “normal” – keep track of oxygen levels (if you use a pulse oximeter), peak flow, sputum colour, cough, and breathlessness.

  • Spot infections early – worsening cough, fever, or new sputum colour may mean infection or flare-up. Report these quickly.

Communication with your team

  • Bring notes to clinic – write down questions and symptoms so nothing is forgotten.

  • Be open and honest – if you’ve missed doses, struggled with side effects, or found treatment difficult, let your team know.

  • Keep contact details handy – know who to call if problems arise (specialist nurse, hospital helpline, GP).

Lifestyle and prevention

  • Reduce exposure to moulds – avoid compost heaps, rotting leaves, damp basements, and building dust. If you cannot avoid them, wear an FFP2/3 mask.

  • Protect your lungs – keep up with vaccinations (flu, COVID-19, pneumococcal).

  • Support your overall health – eat well, stay as active as you can, and rest when needed.

  • Look after your mental health – chronic illness is stressful. Patient groups, counselling, or peer support can make a big difference.

Self-management skills

  • Recognise flare-ups – learn the difference between ABPA flare, CPA progression, and bacterial infection symptoms.

  • Know your rescue plan – what to do if you suddenly worsen (extra inhalers, antibiotics, or emergency help).

  • Keep records – note symptoms, hospital visits, and medication changes. This helps spot long-term patterns.

  • Be part of decisions – ask about benefits, risks, and alternatives of treatments. Care should fit your life as well as your lungs.

Where to find reliable information on medicines

Many patients say the leaflet in the medicine box is written in tiny print or feels overwhelming. You do have other options:

  • Ask your clinical team or pharmacist — they can give you a short list of the most important side effects to watch for and explain what’s urgent.

  • Check the BNF (British National Formulary) online — the NHS makes this trusted reference free to the public at bnf.nice.org.uk. It lists side effects, drug:drug interactions, and safety notes.

  • Use NHS.uk — clear pages on most medicines, written in plain English.

  • Patient support organisations — such as the National Aspergillosis Centre or relevant charities, which often provide tailored advice.

If you’re unsure, it’s always safer to ask rather than guess.

The bigger picture: partnership

In the past, doctors made decisions and patients followed instructions. Today, with complex conditions like aspergillosis, patients are central members of the care team.

  • You notice problems first.

  • You take daily responsibility for medication.

  • You decide when to seek help.

This isn’t about shifting the whole burden onto patients — it’s about recognising that care works best when it is a true partnership.

Key message

👉 If you notice something new, strange, or worrying while on antifungal medication — however small — tell your healthcare team. Don’t assume it’s not important.

And remember: safe, effective treatment is a two-way street. Your role as a patient is not just to take medicines, but to observe, record, communicate, and partner with your team. That partnership is what keeps you safe and makes your treatment work.

by GAtherton

👩‍⚕️ Martha’s Law – What It Means for Aspergillosis Patients

Why the law was introduced

  • Martha Mills was a 13-year-old girl who died in 2021 after developing sepsis in hospital.

  • Her parents felt their concerns were not acted on quickly enough and that they were not given access to a second opinion.

  • In response, the government announced Martha’s Law, to ensure patients and families can easily get a second clinical opinion if they feel their concerns are not being taken seriously.

What the law requires

  • Hospitals must provide a clear and simple process for patients and families to request a second opinion from a senior doctor.

  • This right applies when someone feels that:

    • Their symptoms are worsening or not being managed properly.

    • They are not being listened to by the care team.

    • They need reassurance that their treatment plan is the right one.

  • Staff must also inform patients and carers about this right so people know it is available.

Why this matters for people with Aspergillosis

  • Aspergillosis is a rare and complex condition, and not all hospitals or clinicians have specialist knowledge.

  • Symptoms (e.g. breathlessness, chest pain, fever, wheeze, coughing blood) can be misinterpreted as asthma, pneumonia, or something less serious.

  • Martha’s Law means that if you or your family feel your care isn’t right, you can:

    • Request a second opinion promptly.

    • Be assessed by another senior doctor, potentially with respiratory or infectious disease expertise.

    • Gain access to the National Aspergillosis Centre or another specialist service if appropriate.

What you can do if concerned

  • Speak up early: tell staff if you are worried about your symptoms getting worse.

  • Ask for a second opinion: mention “Martha’s Law” if you feel you’re not being heard.

  • Bring your information: if you’re an aspergillosis patient, carry your clinic letters or patient passport to help new doctors understand your condition.

  • Involve carers/family: they can raise concerns on your behalf if you are too unwell.

✅ In summary: Martha’s Law ensures that patients and families have the right to be heard and to request a second medical opinion. For people with aspergillosis, this could be life-saving when symptoms are worsening and urgent, specialist input is needed.

by GAtherton

Housing Reforms That Matter for Aspergillosis Patients

1. Awaab’s Law – Protecting Against Damp & Mould

  • Born from the tragic death of toddler Awaab Ishak, Awaab’s Law mandates swift action on damp and mould in social housing.

  • Phase 1 (from 27 October 2025):

    • Emergency hazards addressed within 24 hours.

    • Investigations into mould/damp begin within 10 working days.

    • Findings communicated within 3 working days.

    • Repairs completed within 5 working days, with alternative housing offered if unsafe.
      Chartered Institute of HousingGOV.UK

For aspergillosis patients, this delivers critical protection—damp environments exacerbate lung disease, and timely remediation can make a real health difference.

2. Decent Homes Standard (DHS) – Public Consultation Open

The government is reviewing and expanding the Decent Homes Standard to include both social and private rented sectors.

Why this matters for you: Contributing your experiences—especially how damp or poor insulation worsen aspergillosis—can help shape a standard that better protects lung health.

3. Electrical Safety Regulations for Social Landlords

  • From November 2025 (new tenancies) and May 2026 (existing tenancies), social landlords must:

    • Perform electrical safety checks (EICR) every five years.

    • Supply tenants or new occupants with the inspection report within 28 days.

    • Conduct Portable Appliance Testing (PAT) and fix any hazards within 28 days.
      GOV.UKTrowers & Hamlins

Why it matters: Safe electrics reduce the risk of fires and power outages, which can be particularly dangerous during respiratory flare-ups or hospital recovery.

4. Other Related Reforms & Building Safety Measures

  • Gas Safety: Landlords must continue annual checks of gas appliances and provide tenants with a valid Gas Safety Certificate (CP12).
    Wikipedia

  • Building Safety Act & Regulations (Part P): Ensures electrical work (like rewiring or EV charger installations) meets safety standards—crucial for safe, modern living environments.
    HomebuildingWikipedia

  • Energy Efficiency Reforms: Proposals (not yet enacted) suggest requiring rented homes to reach a C rating on Energy Performance Certificates (EPC) by 2030 to reduce fuel poverty and keep homes warm.
    The TimesThe Guardian

Summary Table

Reform / Law Scope & Timing Why It Matters for Aspergillosis Patients
Awaab’s Law – Phase 1 From 27 Oct 2025 Ensures damp/mould issues are addressed fast
Decent Homes Standard Consultation 2 Jul – 10 Sep 2025 Influences future standards to protect lung health
Electrical Safety Regulations From Nov 2025 / May 2026 (depending on tenancy) Mitigates fire/electrical risks in homes
Gas Safety Standards Ongoing requirement Prevents gas-related hazards in vulnerable patients
Building Safety & Part P Rules Already in effect Ensures electrical works meet safety compliance
Energy Efficiency Initiatives Proposed for 2030+ Promotes warm, dry living conditions

What You Can Do

  1. Submit to the DHS consultation by 10 September, sharing your stories of how damp or poor heating affects your lung health.

  2. Report damp or mould to your landlord and ask for Awaab’s Law protections—mention the upcoming deadlines.

  3. Ensure safety checks are done—ask your landlord for the EICR or gas safety certificate.

  4. Highlight your needs—if you have aspergillosis, a doctor’s note can underline the urgency for timely action.

Would you like help drafting a consultation response template or patient-facing summary sheet to guide people through these updates? Just let me know!

Further reading
Landlords face ban on renting homes that are not energy efficient

The Times

Landlords face ban on renting homes that are not energy

by GAtherton

National Aspergillosis Centre Video Recordings

NAC Monthly Patient Meetings

The NAC monthly patient meetings provide a friendly, supportive, and informative space for anyone living with aspergillosis or related conditions. Hosted by the National Aspergillosis Centre (NAC), these sessions bring together patients, carers, and healthcare professionals to:

  • share personal experiences

  • ask questions in a safe environment

  • hear the latest updates on treatments, research, and self-care strategies

🎥 Watch past sessions
Our YouTube channel now has 87 recordings, covering everything from expert talks to personal patient stories. Whatever your stage in the journey — newly diagnosed or managing your condition for years — you’ll find something helpful and relatable.

👉 Browse all recordings here

Recent Highlights

  • September — Explored how Artificial Intelligence can support patients in finding trustworthy information. We also answered community questions about biologic medications, looking at what research tells us about their long-term effectiveness in asthma and ABPA.

  • August — Focused on new biologics for severe asthma, discussing why they don’t always work for everyone, and why some patients see benefits fade over time.

  • July — Shared updates from the British Thoracic Society meeting in Manchester, plus further insights into what the future may hold for biologic treatments.

💡 Whether you want practical advice, the latest medical updates, or simply the chance to connect with others who truly understand your journey, the NAC monthly meetings are here for you.

by GAtherton